Can Artificial Intelligence Read Your Mind? Not Yet, but They Are Getting Better!

Featured

Artificial intelligence (AI) has made impressive strides in recent years, and one of the most intriguing applications of this technology is the ability to read people’s minds. Researchers are using advanced techniques such as functional magnetic resonance imaging (fMRI) to decode neural activity in the brain and reconstruct the images people see. This is an exciting development, as it offers a unique way to understand how the brain represents the world and the connection between computer vision models and our visual system.

One major challenge in this field is the reconstruction of realistic images with high semantic fidelity. While deep generative models have been employed for this task, the image reconstruction quality for real-world images remains a complex problem. One of the main difficulties is the variability of natural images, which require accurate reconstruction of color, shape, and higher-level perceptual features.

However, recent research has made significant progress in this area. For example, a study used a diffusion model to reconstruct real-world images from fMRI data, which reduces the computational cost of deep models while preserving high generative performance. This AI model even predicted objects hidden behind masks, similar to how our brain automatically processes this information (see the image below). Another study applied a variational auto-encoder neural network using a generative adversarial network unsupervised procedure to reconstruct face images from fMRI data. The system could perform robust pairwise decoding, accurate gender classification, and even decode which face was imagined rather than seen.

Despite these advancements, AI-based visual reconstruction still needs to address many challenges. The lack of a standardized evaluation procedure for assessing the reconstruction quality makes it difficult to compare existing methods. Additionally, the brain’s visual representations are invariant to different objects or image details, meaning brain activation patterns are not necessarily unique for a given stimulus object.

In conclusion, while AI may not yet be able to read your mind, researchers are making great strides in understanding how the brain processes visual information and reconstructing the images people see. This could have important implications for brain-computer interfaces and our understanding of the brain’s visual processing mechanisms.

Who knows what new advances in AI and neuroscience may bring next?

No More Nerdy Glasses with These Clinically Proven Non-Invasive Methods!

Featured

We’re sorry for the scientific jargon and numbers in this blog, but we wanted to make sure our information was accurate. We hope it didn’t make your brain hurt too much!

Go outdoors and play!

An international team of researchers conducted a study in China – the country reportedly is heavily affected by nearsightedness. They aimed to evaluate if increasing the time children spent outdoors at school could prevent the development of nearsightedness. Over a period of 3 years, the study added 40 minutes of outdoor activities for six schools and kept the activity levels unchanged for another six schools. The results showed that the children who spent more time outdoors had a lower incidence rate of nearsightedness. This study highlights the potential effectiveness of outdoor activities as an intervention to prevent nearsightedness in children. Citation: https://doi.org/10.1001/jama.2015.10803

Eye drops: low-concentration atropine

A study conducted in Hong Kong evaluated the effectiveness of low-concentration atropine eye drops in delaying the onset of myopia in children aged 4 to 9. The study administered eye drops of either 0.05% atropine, 0.01% atropine, or a placebo to the children for two years. Results showed that the group given 0.05% atropine had a significantly lower incidence of myopia and a lower percentage of participants with fast myopic shift compared to the placebo group. However, there was no significant difference between the 0.01% atropine and placebo groups. The study highlights the potential efficacy of low-concentration atropine eye drops for delaying the onset of myopia in children. Eye doctors are waiting to see the long-term safety and efficacy data. Citation: https://doi.org/10.1001/jama.2022.24162

What is atropine? Atropine is a medication commonly used to dilate the eye’s pupils for specific medical procedures. It works by blocking a chemical in the body that causes muscles to contract, and this can have different effects on the body depending on the dose and route of administration. In some cases, atropine can be used to treat other medical conditions, such as heart problems, but it can also have side effects and should only be used under the guidance of a healthcare professional.

Low-level red-light therapy

A new treatment called repeated low-level red-light therapy (mimicking the beneficial effects of sunshine) is studied for nearsightedness control. In a clinical trial with 112 children, those who received the red-light therapy had significantly less nearsightedness progression than those who used a sham red-light device with only 10% power. The low-level red-light therapy was administered at home and was well-tolerated with no reported adverse effects. The results suggest that low-level red-light therapy could effectively and safely control nearsightedness progression in children. Citation: https://doi.org/10.1016/j.ophtha.2022.08.024